株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のハイスループットスクリーニング(HTS)市場

High Throughput Screening (HTS)

発行 Global Industry Analysts, Inc. 商品コード 236872
出版日 ページ情報 英文 339 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.97円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
世界のハイスループットスクリーニング(HTS)市場 High Throughput Screening (HTS)
出版日: 2017年09月01日 ページ情報: 英文 339 Pages
概要

当レポートでは、世界のハイスループットスクリーニング(HTS)市場について調査し、市場の動向と2016〜2024年の予測、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • ハイスループットスクリーニング(HTS):序論
    • 創薬プログラムの主流技術
    • 化合物スクリーニングにおけるメリットが幅広い導入を促進
    • 主なメリット:概要
    • 先進国:主な収益貢献国
    • 途上国での導入が広がりつづける
    • 競合シナリオ
    • 主要企業
    • M&A活動
  • 市場動向、成長促進因子
  • 製品概要
    • ハイスループットリサーチ
    • HTS製品の種類
    • HTS技術
    • HTSプロセス:概要
  • 創薬:概要
  • 製品/サービス導入
  • 近年の業界活動
  • 世界の主要企業
    • Agilent Technologies, Inc.
    • Aurora Biomed, Inc.
    • Axxam SpA
    • BD Biosciences
    • Danaher Corporation
    • Beckman Coulter, Inc.
    • Molecular Devices Inc.
    • Pall ForteBio LLC
    • Bio-Rad Laboratories, Inc.
    • BioTek Instruments Inc.
    • BMG LABTECH GmbH
    • Charles River Laboratories International, Inc.
    • Corning Inc.
    • DiscoveRx Corporation
    • Evotec AG
    • F. Hoffmann-La Roche Ltd.
    • Genedata AG
    • IntelliCyt® Corporation
    • Luminex Corporation
    • PerkinElmer, Inc.
    • Sigma-Aldrich Corp.
    • Tecan Group Ltd
    • Thermo Fisher Scientific Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の諸国

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6755

This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million. The Global market is further analyzed by the following Product Segments and Technology Types - Product Segments: Consumables/Reagents, Instruments, and Software and Services; and Technology Types: Label-Free Technology, Cell-Based Assay, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 104 companies including many key and niche players such as -

Agilent Technologies, Inc.
Aurora Biomed, Inc.
Axxam SpA
BD Biosciences
Bio-Rad Laboratories, Inc.
Danaher Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Product Types
      • Consumables/Reagents
      • Instruments
      • Software
      • Services
    • Technology Types
      • Label-Free Technology
      • Cell-Based Assay
      • Others

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • High Throughput Screening (HTS): A Prelude
  • HTS: The Mainstream Technology for Drug Discovery Programs
  • Unparalleled Advantages in Compound Screening Drives Wider Adoption
  • Key Benefits of HTS - An Overview
    • Investigate Vast Number of Modulators
    • Accelerated Target Interrogation
    • Generate Highly Relevant Data for Latter Stage Screening
    • Scaling Efficiency
    • Reduced Costs
  • Soaring R&D Spending Creates Conducive Environment for HTS
    • Table 1: Healthcare Spending as a Percentage (%) of National GDP for Select Developed Nations (2014) (includes corresponding Graph/Chart)
    • Table 2: Healthcare Spending as a Percentage (%) of National GDP for Select Developing Nations (2014) (includes corresponding Graph/Chart)
  • Shift towards High Throughput Research Builds Momentum for HTS
  • Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
  • Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term
    • Table 3: World Real GDP Growth Rates in % (2016-2018P): Breakdown by Country/Region (includes corresponding Graph/Chart)
  • Developed Regions: Key Revenue Contributors
  • HTS Adoption Continues to Expand in Developing Regions
  • Key Factors Driving Demand for HTS in the Developing Regions
    • Rising Healthcare and R&D Spending
    • Uptrend in Pharmaceutical, Biotech & CRO Sectors
  • Competitive Scenario
  • Leading Players in the World HTS Market
  • M&A Activity
    • Select M&A Deals in the HTS Domain (2014-2017)

2. KEY MARKET TRENDS & GROWTH DRIVERS

  • Cell-based Assay: The Widely Used HTS Technology
  • Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
  • HTS Aims to Expand Use Case in Biochemical Applications
  • Label-Free HTS Demonstrates Fastest Growth
  • Lab-on-a-Chip HTS Seeks to Proliferate the Market
  • Bioinformatics HTS Enhanced with Computational Algorithms
  • Positive Prognosis across End-Use Markets to Underpin Revenue Growth
    • Table 4: Global High Throughput Screening Market by End-Use Sector (2016): Percentage Breakdown of Revenues for Academia, Biotechnology, Contract Research Organizations (CROs), Government R&D, Pharmaceutical and Other Sectors (includes corresponding Graph/Chart)
  • Pharmaceutical Industry Leads the Way
  • HTS Deployments Soar in Academia
  • Progressive Advancements in HTS Instruments Accelerate Market Growth
  • Microplate Handling Systems: An Important HTS Instrument Type
    • Microplates
    • Microplate Readers
  • Liquid Handling Devices: A Necessity in HTS Processes
  • Microscopic Systems Facilitate Seamless Quantitative Analysis
  • Advanced Software Platforms Augment HTS Proficiency
  • Services: An Important Revenue Generating Segment
  • Expansion in Compound Libraries Widens Functional Scope of HTS
  • Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
  • Laboratory Automation & Miniaturization Spell Opportunities for HTS
  • Miniaturization of Compound Screening Processes Drives Demand for HTS
  • HTS Miniaturization - Technology Developments
  • HTS Robotics Support Miniaturization
  • IVC - A Miniaturized, Powerful HTS Technology
  • HTS Assumes Critical Importance in Target Identification & Validation
  • HTS Gathers Steam in Primary Screening Applications
  • HTS Perceives Bright Future in Stem Cell Research
  • HTS in Kinase Inhibitors Identification
  • HTS in Alzheimer's Disease Drug Discovery
  • HTS for Less Simplified PCR Systems
  • HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
  • Open Access Platforms Widen HTS Audience Base
  • Need for Stringent QA System to Keep Failures at Bay
  • High Throughput Screening (HTS) Vs. High Content Screening (HCS)
  • Rise in Adoption of HCS Technology in HTS Laboratories

3. PRODUCT OVERVIEW

  • High Throughput Research (HTR)
  • HTS Product Types
  • Consumables/Reagents
  • Instruments
  • Software
  • Services
  • HTS Technologies
  • Label-Free Technology
  • Cell-Based Assay
  • Others
  • HTS Process: An Overview
  • Functional and Non-Functional - Two Types of High Throughput Assays
  • HTS: A Historical Perspective

4. DRUG DISCOVERY - AN OVERVIEW

  • Drug Discovery - Definition
  • Drug Discovery Process
  • Drug Discovery Technologies
  • Computer Aided Drug Discovery (CADD)
  • The Evolution of Computer Aided Drug Discovery (CADD) Processes
  • High Throughput Screening
  • Virtual Screening
  • Cloud Computing
  • Hit and Lead Generation Strategies
  • Different Stages in Hit and Lead Generation
  • From 'Hit' to 'Lead' in HTS - A Complex Endeavor

5. PRODUCT/SERVICE LAUNCHES

  • Bio-Rad and Illumina Unveil Illumina(r) Bio-Rad(r) Single-Cell Sequencing Solution
  • DiscoverX Unveils PathHunter(r) Checkpoint Receptor Screening & Profiling Services
  • Roche Launches cobas(r) CT/NG for cobas(r) 6800/8800 Systems
  • PerkinElmer Introduces Vectra(r) Polaris(tm) Automated Quantitative Pathology Imaging System
  • Bruker Rolls Out MALDI PharmaPulse 2.0
  • Genedata Unveils New Solution for High-Throughput Automated Patch Clamp Experiments
  • Genedata Unveils Genedata Screener(r) Version 14
  • BD Rolls Out BD CLiC(tm) System
  • Molecular Devices Unveils Upgraded Version of MetaXpress(r) High-Content Image Acquisition and Analysis Software
  • Crown Bioscience Unveils Huscreen(tm) High Throughput Oncology Service Platform
  • Catalent Pharma Solutions Extends OptiForm(r) Solution Suite for Macromolecule Rapid Screening
  • OptraSCAN Unveils Subscription Scheme for High Throughput Whole Slide Imaging
  • Core Informatics Unveils New Applications for Therapeutic Biologics Discovery & Development
  • Horizon Discovery Introduces New High Throughput Platform for Immuno-Oncology Research
  • Bruker Unveils MALDI PharmaPulse(tm) HTS Platform
  • BellBrook Labs Launches TR-FRET Version of Transcreener UDP HTS Assay

6. RECENT INDUSTRY ACTIVITY

  • Eurofins Pharma Discovery Services Acquires DiscoverX
  • Sartorius Group Acquires Essen BioScience
  • Evotec and MaRS Innovation Establish Fibrocor Therapeutics
  • Axxam Joins PHAGO Project
  • Charles River to Expand Bioactivity Testing Lab Capacities in Germany
  • Evotec Teams Up with Asahi Kasei Pharma
  • PerkinElmer to Take Over Euroimmun Medical Laboratory Diagnostics
  • Evotec Takes Over Aptuit
  • STORM Therapeutics Partners with Evotec
  • TTP Labtech Teams Up with Genedata
  • Pluriomics Collaborates with Pivot Park Screening Centre
  • PerkinElmer to Acquire Tulip Diagnostics
  • Sartorius Takes Over IntelliCyt
  • Thermo Fisher Scientific Acquires Affymetrix
  • Thermo Fisher Scientific Snaps Up FEI Company
  • Tecan Group Takes Over SPEware
  • Evotec Selects Genedata Screener for its HTS Unit
  • Evotec Snaps Up Cyprotex
  • AstraZeneca Collaborates with IntelliCyt
  • Massachusetts General Hospital Teams Up with IntelliCyt
  • Twist Bioscience Expands Collaboration with Ginkgo Bioworks
  • Icagen Acquires Ultra High-Throughput Assets of Sanofi
  • Albany Molecular Research and New York Center for Nanomedicine Research Team Up
  • Genedata Extends License Deal with Ono Pharmaceutical
  • IDBS and Cancer Research Technology Team Up
  • PerkinElmer Acquires Vanadis Diagnostics
  • Aptuit Acquires Exquiron Biotech
  • BGI Selects Solvay's KetaSpire(r) PEEK for its BGISEQ-500 HTS System
  • Novogene and AITbiotech to Establish NovogeneAIT Genomics Singapore
  • Teva Pharmaceutical Industries Collaborates with AbCellera
  • Merck Acquires Sigma-Aldrich
  • JEOL USA Teams Up with IMRI
  • CIRCE Teams Up with Freeslate
  • Dow AgroSciences Inks License Agreement with Critical Path Services
  • TMG Collaborates with Verdeca
  • Albany Molecular Research Signs Collaborative Agreement with Multispan
  • Cyprotex Inaugurates New HTS Laboratory in the US
  • The Institut Pasteur Inks Partnership Agreement with IntegraGen
  • Charles River Laboratories Acquires Oncotest
  • Exquiron Inks Partnership Agreement with SAMDI Tech
  • Vaccinogen Inks Option Agreement with Dublin City University

7. FOCUS ON SELECT GLOBAL PLAYERS

  • Agilent Technologies, Inc. (USA)
  • Aurora Biomed, Inc. (Canada)
  • Axxam SpA (Italy)
  • BD Biosciences (USA)
  • Danaher Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • Molecular Devices Inc. (USA)
  • Pall ForteBio LLC (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • BioTek Instruments Inc. (USA)
  • BMG LABTECH GmbH (Germany)
  • Charles River Laboratories International, Inc. (USA)
  • Corning Inc. (USA)
  • DiscoveRx Corporation (USA)
  • Evotec AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genedata AG (Switzerland)
  • IntelliCyt(r) Corporation (USA)
  • Luminex Corporation (USA)
  • PerkinElmer, Inc. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Tecan Group Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE

    • Table 5: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 6: World Historic Review for High Throughput Screening (HTS) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 7: World 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 8: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Product Type - Consumables/Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for High Throughput Screening (HTS) by Product Type - Consumables/ Reagents, Instruments, and Other Products Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 10: World 14-Year Perspective for High Throughput Screening (HTS) by Product Type - Percentage Breakdown of Revenues for Consumables/Reagents, Instruments, and Other Products Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 11: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 12: World Historic Review for High Throughput Screening (HTS) by Technology Type - Label-Free Technology, Cell-Based Assay, and Other Technology Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 13: World 14-Year Perspective for High Throughput Screening (HTS) by Technology Type - Percentage Breakdown of Revenues for Label-Free Technology, Cell-Based Assay, and Other Technology Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • HTS Assumes Critical Importance in Drug Discovery Projects
    • Spending on HTS Soars in Pharmaceutical Sector
    • Cell-Based Assays Gain Popularity
    • HTS Outsourcing Gathers Steam
    • Product/Service Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 14: US Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 15: US Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 16: Canadian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 17: Canadian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 18: Japanese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 19: Japanese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Market Shifts Towards Maturity - Technological Innovations Come to the Rescue
    • HTS in European Pharmaceutical Industry
    • Clinical Trials Market in Europe
    • Innovations in Cell Culture Drive Adoption of Cell-based Assay HTS
    • Label-Free Technologies Aim to Penetrate the Market
  • B. Market Analytics
    • Table 20: European Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 21: European Historic Review for High Throughput Screening (HTS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 22: European 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 23: French Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 24: French Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 25: German Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 26: German Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
    • Key Player
  • B. Market Analytics
    • Table 27: Italian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 28: Italian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Product/Service Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 29: The UK Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 30: The UK Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 31: Spanish Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 32: Spanish Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 33: Russian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 34: Russian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Product/Service Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 35: Rest of Europe Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 36: Rest of Europe Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Asia-Pacific Emerges as Fastest Growing Market for HTS
    • Pharmaceutical & Biotech Industries Lead the Way
  • B. Market Analytics
    • Table 37: Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 38: Asia-Pacific Historic Review for High Throughput Screening (HTS) by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 39: Asia-Pacific 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Outlook
    • Opportunities in Expanding in the Chinese Life Sciences Sector
    • Growing Drug Discovery Outsourcing Market Bodes Well for Market
      • Few Problem Areas Exist...
      • What Outsourcers Need to Look Forward to...
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 40: Chinese Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 41: Chinese Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Market Overview
    • HTS Seeks Role in Indian Pharmaceutical Industry
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 42: Indian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: Indian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 44: Rest of Asia-Pacific Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 45: Rest of Asia-Pacific Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 46: Latin American Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 47: Latin American Historic Review for High Throughput Screening (HTS) by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 48: Latin American 14-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 49: Brazilian Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 50: Brazilian Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 51: Rest of Latin America Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 52: Rest of Latin America Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 53: Rest of World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 54: Rest of World Historic Review for High Throughput Screening (HTS) Market Analyzed with Annual Revenues in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top